- Home
- / Sunshine Guojian Pharmaceutical
Sunshine Guojian Pharmaceutical
Stock Price
¥23.8
2024-10-29
Market Capitalization
¥14.4 B
2024-10-29
Revenue
¥4.2 B
FY, 2025
Sunshine Guojian Pharmaceutical Summary
Company Summary
- Overview
- Sunshine Guojian Pharmaceutical (三生国健药业(上海)股份有限公司) is a biopharmaceutical company that develops, produces, and sells antibody drugs. It offers cipterbin, yisaipu, xenopax, and other medicines.
- Type
- Public
- Status
- Active
- Founded
- 2002
- Website
- https://www.3s-guojian.com
- Cybersecurity rating
Table of Contents
Sunshine Guojian Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥426.8M
- Gross profit (Q1, 2026)
- ¥343.6M
- Net income (Q1, 2026)
- ¥176.6M
- Cash (Q1, 2026)
- ¥282.6M
- EBIT (Q1, 2026)
- ¥206.6M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026